Decoy Therapeutics, Inc. (DCOY)
3.04
-0.01
(-0.33%)
USD |
NASDAQ |
Sep 01, 09:58
Decoy Therapeutics Cash from Operations (TTM) : -8.324M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.324M |
| March 31, 2026 | -6.535M |
| December 31, 2025 | -4.827M |
| September 30, 2025 | -4.433M |
| June 30, 2025 | -4.143M |
| March 31, 2025 | -4.353M |
| December 31, 2024 | -4.525M |
| September 30, 2024 | -5.294M |
| June 30, 2024 | -7.686M |
| March 31, 2024 | -11.03M |
| December 31, 2023 | -12.85M |
| September 30, 2023 | -16.05M |
| June 30, 2023 | -18.04M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -10.20M |
| September 30, 2021 | -8.853M |
| June 30, 2021 | -10.02M |
| March 31, 2021 | -9.326M |
| Date | Value |
|---|---|
| December 31, 2020 | -10.31M |
| September 30, 2020 | -11.57M |
| June 30, 2020 | -14.36M |
| March 31, 2020 | -13.42M |
| December 31, 2019 | -11.58M |
| September 30, 2019 | -8.556M |
| June 30, 2019 | 18.44M |
| March 31, 2019 | 11.72M |
| December 31, 2018 | 4.177M |
| September 30, 2018 | -1.966M |
| June 30, 2018 | -31.47M |
| March 31, 2018 | -28.91M |
| December 31, 2017 | -27.72M |
| September 30, 2017 | -28.27M |
| June 30, 2017 | -27.47M |
| March 31, 2017 | -31.10M |
| December 31, 2016 | -32.05M |
| September 30, 2016 | -31.19M |
| June 30, 2016 | -30.64M |
| March 31, 2016 | -25.78M |
| December 31, 2015 | -20.75M |
| September 30, 2015 | -19.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Palatin Technologies, Inc. | -14.93M |
| Unicycive Therapeutics, Inc. | -27.84M |
| Nuvectis Pharma, Inc. | -19.51M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |